Investor Information






 
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 10-K

Annual Report Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934


For the fiscal year ended December 28, 2008
Commission File No. 0-21794

THIS IS AN ADOBE PDF FILECLICK HERE FOR FORM 10-K, 2008

 
 
For the fiscal year ended December 30, 2007
Commission File No. 0-21794

THIS IS AN ADOBE PDF FILECLICK HERE FOR FORM 10-K/A, 2007

 
 
For the fiscal year ended December 30, 2007
Commission File No. 0-21794

THIS IS AN ADOBE PDF FILECLICK HERE FOR FORM 10-K, 2007

 
 
For the fiscal year ended December 31, 2006
Commission File No. 0-21794

THIS IS AN ADOBE PDF FILECLICK HERE FOR FORM 10-K, 2006

 
 
For the fiscal year ended January 1, 2006
Commission File No. 0-21794

THIS IS AN ADOBE PDF FILECLICK HERE FOR FORM 10-K, 2005

 
 
For the fiscal year ended January 2, 2005
Commission File No. 0-21794

THIS IS AN ADOBE PDF FILECLICK HERE FOR FORM 10-K, 2004

 
 
For the fiscal year ended December 28, 2003
Commission File No. 0-21794

THIS IS AN ADOBE PDF FILECLICK HERE FOR FORM 10-K, 2003

 
 
For the fiscal year ended December 29, 2002
Commission File No. 0-21794

THIS IS AN ADOBE PDF FILECLICK HERE FOR FORM 10-K, 2002

 
 
For the fiscal year ended December 31, 2001
Commission File No. 0-21794

THIS IS AN ADOBE PDF FILECLICK HERE FOR FORM 10-K, 2001

 
 
For the fiscal year ended December 31, 2000
Commission File No. 0-21794

THIS IS AN ADOBE PDF FILECLICK HERE FOR FORM 10-K, 2000

 
 
For the fiscal year ended January 2, 2000
Commission File No. 0-21794

THIS IS AN ADOBE PDF FILECLICK HERE FOR FORM 10-K, 1999

 
 
This is an Adobe Acrobat file.

Get Acrobat Reader from Adobe

 

Copyright 2006 GTC Biotherapeutics, All Rights Reserved